<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="62224">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02087436</url>
  </required_header>
  <id_info>
    <org_study_id>INT.CR.GH3.13</org_study_id>
    <nct_id>NCT02087436</nct_id>
  </id_info>
  <brief_title>Taperloc Complete Microplasty vs Taperloc Complete Standard: Randomized Controlled Study on Bone Mineral Density</brief_title>
  <acronym>taperloc</acronym>
  <official_title>Taperloc Complete Microplasty vs Taperloc Complete Standard: Randomized Controlled Study on Bone Mineral Density</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biomet, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biomet, Inc.</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to measure the postoperative changes in bone mineral
      density, comparing the Taperloc Complete Reduced Distal Microplasty stem and the standard
      length Taperloc Complete Reduced Distal stem.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Taperloc Microplasty cementless stem is designed to transmit load to the proximal femur,
      thereby preserving bone density, and preventing long term instability and loosening
      secondary to proximal bone resorption.   The primary aim of this study is therefore to
      compare the postoperative changes in bone density with the Taperloc Microplasty stem, using
      the standard length Taperloc stem as a control.

      In addition, the Taperloc stem has historically had a neck angle of 138°.   There have been
      criticisms that this neck angle is too high for the typical Korean population.    The newer
      Taperloc Complete system (both Microplasty and standard length) has a neck angle of 133°.
      A secondary aim is Occurrence ratio of thigh pain difference between Microplasty and
      standard stem in Korean Population
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Bone Mineral Density</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>evaluate bone mineral density around the implant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiographic Evaluation,</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radiographic measurements of stability and fixation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS Score</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>The measurement of pain intensity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Harris Hip Score</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Over all Survivorship
Harris Hip Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Evaluation</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radiographic measurements of stability and fixation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Evaluation</measure>
    <time_frame>6 Weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radiographic measurements of stability and fixation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS Score</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The measurement of pain intensity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS Score</measure>
    <time_frame>6 Weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>The measurement of pain intensity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS Score</measure>
    <time_frame>6 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The measurement of pain intensity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Harris Hip Score</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Over all Survivorship
Harris Hip Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Harris Hip Score</measure>
    <time_frame>6 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Over all Survivorship
Harris Hip Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone Mineral Density</measure>
    <time_frame>Immediate post-op(2 - 4Weeks)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Two X-ray beams with different energy levels are aimed at the patient's bones.
DEXA
evaluate the bone mineral density around the implant</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Avascular Necrosis</condition>
  <condition>Traumatic Arthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Legg-Perthes Disease</condition>
  <arm_group>
    <arm_group_label>Taperloc Complete Standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group one will receive a total hip replacement with Taperloc Complete Standard. Taperloc Complete Standard is designed after the philosophy of a flat tapered wedge. It has evolved to incorporate the Reduced Distal and Microplasty stems to better address all patient anatomies, and facilitate multiple surgical techniques.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Taperloc Complete Microplasty</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group one will receive a total hip replacement with Taperloc Complete Microplasty.Taperloc Complete Microplsty cementless stem is designed to transmit load to the proximal femur, thereby preserving bone density, and preventing long term instability and loosening secondary to proximal bone resorption.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Taperloc Complete Microplasty</intervention_name>
    <description>Taperloc Complete Microplsty cementless stem is designed to transmit load to the proximal femur, thereby preserving bone density, and preventing long term instability and loosening secondary to proximal bone resorption.</description>
    <arm_group_label>Taperloc Complete Microplasty</arm_group_label>
    <other_name>Taperloc Complete Microplasty</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Taperloc Complete Standard</intervention_name>
    <description>Taperloc Complete Standard is designed after the philosophy of a flat tapered wedge. It has evolved to incorporate the Reduced Distal and Microplasty stems to better address all patient anatomies, and facilitate multiple surgical techniques.</description>
    <arm_group_label>Taperloc Complete Standard</arm_group_label>
    <other_name>Taperloc Complete Standard</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients suitable for primary Total Hip Replacement

        Patients with degenerative joint disease (inflammatory or non-inflammatory) or any of the
        composite diagnoses of:

          1. Osteoarthritis

          2. Avascular necrosis

          3. Legg Perthes

          4. Rheumatoid Arthritis

          5. Diastrophic variant

          6. Fused hip

          7. Sequelae of Slipped capital epiphysis

          8. Traumatic arthritis

          9. Patients aged over 20

         10. Patients must be able to understand instructions and be willing to return for
             follow-up

        Exclusion Criteria:

          -  Absolute contraindications include: infection, sepsis, and osteomyelitis.

        Relative contraindications include:

          1. uncooperative patient or patient with neurologic disorders who are incapable of
             following directions,

          2. Small Femoral canal

        2) Severe osteoporosis (Patients over 65 years old) 3) metabolic disorders which may
        impair bone formation, 4) osteomalacia, 5) distant foci of infections which may spread to
        the implant site, 6) rapid joint destruction, marked bone loss or bone resorption apparent
        on roentgenogram, and 7) vascular insufficiency, muscular atrophy, or neuromuscular
        disease. 8) pregnancy 9) Fracture of the pelvis 10) Subcapital fractures
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yong-Chan Ha, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chung-Ang University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Young-Kyun Lee, PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Young Kyun Lee, PHD</last_name>
    <phone>82-10-9090-2468</phone>
    <email>ykleemd@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Gyeonggi-do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young-Kyun Lee, PHD</last_name>
      <phone>821090902468</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chung-Ang University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong-Chan Ha, PHD</last_name>
      <phone>821195218328</phone>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>May 1, 2014</lastchanged_date>
  <firstreceived_date>January 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Legg-Perthes Disease</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Osteonecrosis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
